These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Neutralization of extrapyramidal side-effects with Methixene. Maller O; Heller S Dis Nerv Syst; 1971 Jun; 32(6):409-15. PubMed ID: 5570695 [No Abstract] [Full Text] [Related]
28. Movement disorders in multiple sclerosis. Tranchant C; Bhatia KP; Marsden CD Mov Disord; 1995 Jul; 10(4):418-23. PubMed ID: 7565820 [TBL] [Abstract][Full Text] [Related]
29. Drug-induced parkinsonism and other movement disorders. Ross RT Can J Neurol Sci; 1990 May; 17(2):155-62. PubMed ID: 2192787 [TBL] [Abstract][Full Text] [Related]
30. Dyskinetic reactions to phenothiazine drugs and cryptotetany. Muller HR; Kaeser HE Electroencephalogr Clin Neurophysiol; 1969 Jul; 27(1):106. PubMed ID: 4182869 [No Abstract] [Full Text] [Related]
31. Long-acting, antipsychotic agents and extrapyramidal side effects. Simpson GM Dis Nerv Syst; 1970 Sep; 31():Suppl:12-4. PubMed ID: 5476354 [No Abstract] [Full Text] [Related]
32. Nonantipsychotic phenothiazines and tardive dyskinesia. Lipinski J; Baldessarini R N Engl J Med; 1973 Oct; 289(14):752. PubMed ID: 4146969 [No Abstract] [Full Text] [Related]
33. Correlative neuroanatomical and neuropharmacological study of tremor and catatonia in the monkey. Larochelle L; Bédard P; Poirier LJ; Sourkes TL Neuropharmacology; 1971 May; 10(3):273-88. PubMed ID: 4397415 [No Abstract] [Full Text] [Related]
34. Differentiation of tardive dyskinesias and drug-induced Parkinsonism. N Engl J Med; 1971 Jun; 284(24):1382-4. PubMed ID: 5576464 [No Abstract] [Full Text] [Related]
35. Motor dysfunction as a permanent complication of methanol ingestion. Presentation of a case with a beneficial response to levodopa treatment. Guggenheim MA; Couch JR; Weinberg W Arch Neurol; 1971 Jun; 24(6):550-4. PubMed ID: 5089901 [No Abstract] [Full Text] [Related]
36. Clozapine withdrawal symptoms in a Parkinson's disease patient. Zesiewicz TA; Borra S; Hauser RA Mov Disord; 2002 Nov; 17(6):1365-7. PubMed ID: 12465085 [TBL] [Abstract][Full Text] [Related]
37. [On the mode of action and the question of central organic late damages of continuous neuroleptic treatment]. Haddenbrock S Nervenarzt; 1966 May; 37(5):199-203. PubMed ID: 5298253 [No Abstract] [Full Text] [Related]
38. [Progress and limitation of psychopharmacological therapy]. Hoff H; Hofmann G Psychiatr Neurol Med Psychol (Leipz); 1967 Dec; 19(12):441-8. PubMed ID: 6082949 [No Abstract] [Full Text] [Related]
39. [A case of so-called late dyskinetic syndrome appearing early during neuroleptic treatment]. Sizaret P; Degiovanni A Ann Med Psychol (Paris); 1974 Feb; 1(2):247-9. PubMed ID: 4858843 [No Abstract] [Full Text] [Related]
40. [On the problem of fixed extrapyramidal disorders following prolonged use of neuroleptics]. Krystof J; Kajzer J Psychiatr Pol; 1967; 1(3):289-93. PubMed ID: 5593256 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]